Tag
This review synthesizes current evidence on neurodevelopmental outcomes after treating retinopathy of prematurity with anti-VEGF injections versus laser photocoagulation, finding no significant differences in long-term cognitive or developm
Systemic IL-6 inhibitors are linked to significantly reduced risks of diabetic retinopathy development, progression, and vision-threatening complications, suggesting therapeutic potential for diabetic eye disease.
A longitudinal study of 603 patients demonstrates that chronic intravitreal anti-VEGF therapy significantly accelerates cataract development, particularly posterior subcapsular opacities, resulting in an eightfold increased risk for catarac
A recent randomized, double-blind trial demonstrates that oral lamivudine significantly improves visual acuity in patients with center-involved diabetic macular edema, offering a cost-effective and safer alternative to conventional anti-VEG
